AGL 8.62 Increased By ▲ 0.32 (3.86%)
ANL 10.65 Increased By ▲ 0.06 (0.57%)
AVN 79.50 Increased By ▲ 0.90 (1.15%)
BOP 5.55 Increased By ▲ 0.10 (1.83%)
CNERGY 5.42 Decreased By ▼ -0.17 (-3.04%)
EFERT 80.00 Decreased By ▼ -0.25 (-0.31%)
EPCL 71.20 Increased By ▲ 1.60 (2.3%)
FCCL 15.32 Increased By ▲ 0.02 (0.13%)
FFL 6.63 Increased By ▲ 0.10 (1.53%)
FLYNG 7.35 Increased By ▲ 0.17 (2.37%)
GGGL 10.93 Increased By ▲ 0.08 (0.74%)
GGL 16.92 Increased By ▲ 0.13 (0.77%)
GTECH 8.28 Increased By ▲ 0.14 (1.72%)
HUMNL 7.17 Increased By ▲ 0.13 (1.85%)
KEL 2.96 Decreased By ▼ -0.03 (-1%)
LOTCHEM 32.89 Increased By ▲ 2.12 (6.89%)
MLCF 28.82 Decreased By ▼ -0.16 (-0.55%)
OGDC 85.91 Increased By ▲ 3.16 (3.82%)
PAEL 16.85 Decreased By ▼ -0.12 (-0.71%)
PIBTL 6.12 Increased By ▲ 0.04 (0.66%)
PRL 18.05 Decreased By ▼ -0.05 (-0.28%)
SILK 1.17 Increased By ▲ 0.02 (1.74%)
TELE 11.30 Increased By ▲ 0.05 (0.44%)
TPL 9.23 Increased By ▲ 0.03 (0.33%)
TPLP 19.90 Increased By ▲ 0.02 (0.1%)
TREET 26.66 Increased By ▲ 0.20 (0.76%)
TRG 95.91 Increased By ▲ 1.31 (1.38%)
UNITY 19.64 Increased By ▲ 0.14 (0.72%)
WAVES 14.20 Decreased By ▼ -0.14 (-0.98%)
WTL 1.31 Increased By ▲ 0.01 (0.77%)
BR100 4,251 Increased By 63.7 (1.52%)
BR30 15,687 Increased By 213.4 (1.38%)
KSE100 42,679 Increased By 582.4 (1.38%)
KSE30 16,149 Increased By 266.6 (1.68%)

NEW YORK: The US Food and Drug Administration on Monday authorized the use of a third dose of the Pfizer and BioNTech Covid-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots to 5 months from 6 months after primary doses.

The agency also authorized a third shot in children aged 5 through 11 years who are immunocompromised. The FDA said it reviewed published data and real world evidence on the safety of booster doses provided by the Israeli Ministry of Health including data from over 6,300 individuals 12-to-15 years of age who received a Pfizer shot.

Global COVID-19 cases are surging due to the Omicron variant and health authorities have warned that its extremely high transmissibility could overwhelm many health systems. Laboratory tests have shown that two doses of the Pfizer-BioNTech and Moderna vaccines generate low immune responses against Omicron, while boosters appear to be protective against the highly-mutated variant.

Comments

Comments are closed.